Table 1 Characteristics of the 65 women with an intrauterine fetal death and antiphospholipid syndrome
From: Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women
Age at IUFD, median [IQR] | 29 [26–33] |
Follow up since IUFD, median [IQR] | 4 [2–9] |
Gestational age at IUFD (weeks), median [IQR] | 24 [18–27] |
History of live birth before the IUFD, n (%) | 11 (17) |
History of live birth overall, n (%) | 54 (83) |
Antibody profile | |
Anticardiolipin, n (%) | 46 (71) |
Anticardiolipin IgG | 43 (66) |
Anticardiolipin IgM | 8 (12) |
Lupus anticoagulant, n (%) | 47 (72) |
Lupus anticoagulant - aPTT-based and dRVVT assay | 34 (52) |
Lupus anticoagulant-dRVVT assay | 13 (20) |
Anti-β2GP1, n (%) | 33 (51) |
Anti-β2GP1 IgG | 31 (48) |
Anti-β2GP1 IgM | 8 (12) |
Triple-positive, n (%) | 23 (35) |
History of thrombosis before the IUFD, n (%) | 14 (22) |
History of thrombosis overall, n (%) | 28 (43) |
Associated SLE before the IUFD, n (%) | 9 (14) |
Associated SLE overall, n (%) | 19 (29) |